Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2
AssigneeBoston Biomedical Research Institute
InventorsRuben Rene Gonzalez, Paul C. Leavis
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoston Biomedical Research Institute
InventorsRuben Rene Gonzalez, Paul C. Leavis
Estimating the term…
Disclosed herein are peptides comprising a leptin sequence and methods for their use in preventing ObR signaling in a leptin-responsive cell. A leptin peptide of the present invention binds to but does not activate ObR signaling in a leptin-responsive cell, thereby inhibiting the up-regulatory effects of leptin on ObR signaling in the leptin-responsive cell. Administration of the peptide effectively prevents embryo implantation in a mammal to which the peptide has been administered. Also disclosed herein is a method for identifying a peptide antagonist of ObR, wherein the peptide comprises a leptin sequence.
A method for reducing or inhibiting ObR signaling in a leptin-responsive cell, the method comprising administering to a mammal a therapeutically effective amount of a peptide consisting of SEQ ID NO.:
Dependencies are inferred from the claim text.